Bispecific Antibody Designed for Targeted NK Cell Activation and Functional Assessment for Biomedical Applications-Reference-Cited by-同舟云学术

Bispecific Antibody Designed for Targeted NK Cell Activation and Functional Assessment for Biomedical Applications

Published:2021-09-04 Issue:36 Volume:13 Page:42370-42381
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Song Ah-Young¹,Kim Hyori²,Kim Jung Min¹,Hwang Sang-Hyun³,Ko Dae-Hyun³,Kim Hun Sik¹⁴^ORCID

Affiliation:

1. Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea

2. Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea

3. Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Republic of Korea

4. Stem Cell Immunomodulation Research Center (SCIRC), University of Ulsan College of Medicine, Seoul 05505, Republic of Korea

Funder

Korea Health Industry Development Institute

National Research Foundation of Korea

Asan Institute for Life Sciences, Asan Medical Center

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.1c08986

Reference52 articles.

1. Control of Metastasis by NK Cells

2. The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies

3. Natural killer cells and other innate lymphoid cells in cancer

4. Functions of natural killer cells

5. Natural killer cell memory in infection, inflammation and cancer

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural killer cells affect the natural course, drug resistance, and prognosis of multiple myeloma;Frontiers in Cell and Developmental Biology;2024-02-12

2. The Power of Three: Nanomaterials for Natural Killer (NK) Cell Immunoengineering Maximize Their Potency if They Exploit Multireceptor Stimulation;Advanced Healthcare Materials;2024-01-04

3. NK cell-based tumor immunotherapy;Bioactive Materials;2024-01

4. The potential of monoclonal antibodies for colorectal cancer therapy;Medical Oncology;2023-08-21

5. Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy;Frontiers in Immunology;2023-08-09